| GTO ID | GTD0344 |
| Accession | E-MTAB-11315 |
| Gene therapy-related clinical trial | GTC2404 |
| Altered gene | S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment | ARCT-021(ARCT COVID-19 vaccine) |
| Control | Click to openARCT.101.5104.Day36_09;ARCT.101.5108.Day36_01;ARCT.101.5109.Day36_02;ARCT.101.5116.Day36_07;ARCT.101.6103.Day36_01;ARCT.101.6108.Day36_04;ARCT.101.6110.Day36_10;ARCT.101.6111.Day36_01;ARCT.101.7103.Day36_11;ARCT.101.7105.Day36_01;ARCT.101.7108.Day36_04;ARCT.101.7115.Day36_11;ARCT.101.8105.Day36_05;ARCT.101.8106.Day36_08;ARCT.101.8109.Day36_05;ARCT.101.8112.Day36_02 |
| Case | Click to openARCT.101.6101.Day36_07;ARCT.101.6102.Day36_10;ARCT.101.6104.Day36_04;ARCT.101.6105.Day36_07;ARCT.101.6106.Day36_10;ARCT.101.6107.Day36_01;ARCT.101.6109.Day36_07;ARCT.101.6112.Day36_04;ARCT.101.6113.Day36_07;ARCT.101.6114.Day36_10;ARCT.101.6115.Day36_01;ARCT.101.6116.Day36_04;ARCT.101.8101.Day36_05;ARCT.101.8102.Day36_08;ARCT.101.8103.Day36_11;ARCT.101.8104.Day36_02;ARCT.101.8107.Day36_11;ARCT.101.8108.Day36_02;ARCT.101.8110.Day36_08;ARCT.101.8111.Day36_11;ARCT.101.8113.Day36_05;ARCT.101.8114.Day36_12;ARCT.101.8115.Day36_03;ARCT.101.8116.Day36_06 |
| Disease | COVID-19 |
| Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
| Organism | Homo sapiens |
| Tissue/Cell type | blood |
| Characteristics | Day36;3 microgram |
| Strategy | Microarray |
| Platform | A-MTAB-668 |
| Gene Name | AveExpr Control | AveExpr Case | Log2FC | P-value | Adjusted P-value | Regulation | Boxplot |
|---|
| ID | Terms | Size | ES | NES | P-value | Adjusted P-value | Plot |
|---|